Breaking News

Financial Report: Akorn

February 26, 2013

Achieves record 4Q and FY revenue

Akorn

4Q Revenues: $71.5 million (+68%)

4Q Earnings: $8.8 million  (+54%)

FY Revenues: $256.2 million (+87%)

FY Earnings: $35.4 million (-18%)

Comments: Growth in the quarter and FY was driven by the Lundbeck and Kilitch acquisitions, the sale of newly approved and re-launched products, and growth of established products, offset by decreases in the U.S. contract services business.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important